
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CASE REPORT article
Front. Med.
Sec. Infectious Diseases: Pathogenesis and Therapy
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1556041
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
HIV infection is one of the high-risk factors for pulmonary hypertension (PH). HIV-related PH is associated with non-AIDS-related comorbidities. In this study we report a case of pulmonary hypertension with several concomitant risk factors, who experienced a complete clinical improvement after drug rehabilitation, application of anti-retroviral therapy (ART) and Sildenafil.A 37-year-old HIV-positive man complained about worsening dyspnea was diagnosed with severe PH. PH in this case was characterized by association with multi-factors including amphetamine inhalation, HIV infection, bacterial liver abscess, history of splenectomy and past ventricular septal defect, which was different from previously reported HIV-related PH cases who were associated solely to HIV infection. Our case intends to raise awareness that PH should be suspected among HIV-positive patients with unexplained dyspnea. Notably, investigating the co-existent risk factors and a multidisciplinary team are crucial for early diagnose and better prognosis of HIV-related PH.
Keywords: pulmonary hypertension, HIV infection, Amphetamine, sildenafil, anti-retroviral therapy
Received: 06 Jan 2025; Accepted: 31 Mar 2025.
Copyright: © 2025 Sun, Wen and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ying Wen, China Medical University, Shenyang, China
Yanli Chen, China Medical University, Shenyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.